4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001415889-25-015698
Options or other derivatives
- Director acquired 29,747 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Harrison Seth Loring Director | 2025-06-03 | Grant or award · Director Stock Option (Right to Buy) | +29,747 | 29,747 | D | ||
Loading xslF345X05/form4-06052025_120602.xml…